Hallo! Tracked shipping to Austria with Delivery Duty Paid for just €3.99  

Ship to
Austria
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Nucleosides and Nucleotides as Antitumor and Antiviral Agents
Type
Physical Book
Publisher
Author
Language
English
Pages
336
Format
Paperback
Dimensions
25.4x17.8x1.9 cm
Weight
0.61 kg.
ISBN13
9781461362210
Categories

Nucleosides and Nucleotides as Antitumor and Antiviral Agents

Baker, D. C. ; Chu, C. K. (Author) · Springer · Paperback

Nucleosides and Nucleotides as Antitumor and Antiviral Agents - Baker, D. C. ; Chu, C. K.

Cheaper New Book Imported to Austria
Delivery: 18 Nov - 25 Nov Shipping: 14 to 18 business days.
68,28 €
Faster New Book Imported to Austria
Delivery: 05 Nov - 09 Nov Shipping: 5 to 6 business days.
85,65 €
Import costs and 10% VAT included in the price ✅
68,28 €

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Nucleosides and Nucleotides as Antitumor and Antiviral Agents"

Due to the worldwide epidemic of acquired immunodeficiency syndrome (AIDS), the past ten years have witnessed a flurry of activity in the chemotherapy of viral diseases. Unprecedented scientific efforts have been made by scientists and clinicians to combat infections of human immunodeficiency virus (HIY), the causative agent. Looking back over the past ten years, we have made remarkable progress toward the treatment of the viral disease: isolation of HIV only two years after the identification of the disease, plus major strides in the areas of the molecular biology and virology of the retrovirus, etc. More remarkably, the discovery of the chemotherapeutic agent AZT (Retrovir) was made within two years after the isolation and identification of the virus, followed by unprecedented drug development efforts to culminate in the FDA approval of AZT in twenty-three months, which was a record-breaking time for approval of any drug for a major disease. The last six to seven years have particularly been an exciting and productive period for nucleoside chemists. Since the activity of AZI' was established in 1985, nucleoside chemists have had golden opportunities to discover additional anti-HIV nucleosipes, which are hoped to be less toxic and more effective than AZT, and the opportunity continues. As we all are aware, AZT possesses extremely potent anti-HIY activity, and no other nucleoside or non- nucleoside has surpassed the potency of AZT in vitro.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews